EE9600202A - Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm - Google Patents

Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm

Info

Publication number: EE9600202A
Authority: EE; Estonia
Prior art keywords: carbamazepine; pct; sustained release; sec; release formulation
Prior art date: 1994-07-01

Application number

EE9600202A

Other languages

English (en)

Other versions

EE03954B1 (et

Inventor

Landgraf Karl-Friedrich

Reiss Sabine

Schubert Eberhard

Original Assignee

Arzneimittelwerk Dresden Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-01

Filing date

1995-06-22

Publication date

1997-06-16

1995-06-22 Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh

1997-06-16 Publication of EE9600202A publication Critical patent/EE9600202A/et

2003-02-17 Publication of EE03954B1 publication Critical patent/EE03954B1/et

Links

FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 title abstract 5
229960000623 carbamazepine Drugs 0.000 title abstract 5
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
238000013268 sustained release Methods 0.000 title 1
239000012730 sustained-release form Substances 0.000 title 1
239000013078 crystal Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000004815 dispersion polymer Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EE9600202A 1994-07-01 1995-06-22 Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod EE03954B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19944423078 DE4423078B4 (de)	1994-07-01	1994-07-01	Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de)	1994-07-01	1995-06-22	Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number	Publication Date
EE9600202A true EE9600202A (et)	1997-06-16
EE03954B1 EE03954B1 (et)	2003-02-17

Family

ID=6522000

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9600202A EE03954B1 (et)	1994-07-01	1995-06-22	Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod

Country Status (23)

Country	Link
US (1)	US5888545A (et)
EP (1)	EP0768882B1 (et)
JP (1)	JPH10502358A (et)
KR (1)	KR100344477B1 (et)
CN (1)	CN1101191C (et)
AT (1)	ATE169818T1 (et)
BG (1)	BG62794B1 (et)
BR (1)	BR9508202A (et)
CA (1)	CA2194216A1 (et)
CZ (1)	CZ288028B6 (et)
DE (2)	DE4423078B4 (et)
DK (1)	DK0768882T3 (et)
EE (1)	EE03954B1 (et)
ES (1)	ES2122630T3 (et)
GE (1)	GEP19991819B (et)
HU (1)	HU221486B (et)
LT (1)	LT4251B (et)
LV (1)	LV11820B (et)
PL (1)	PL180979B1 (et)
RU (1)	RU2141825C1 (et)
SK (1)	SK282303B6 (et)
UA (1)	UA32598C2 (et)
WO (1)	WO1996001112A1 (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6162466A (en) *	1999-04-15	2000-12-19	Taro Pharmaceutical Industries Ltd.	Sustained release formulation of carbamazepine
GB9930058D0 (en) *	1999-12-20	2000-02-09	Novartis Ag	Organic compounds
RU2240798C1 (ru) *	2003-06-25	2004-11-27	Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"	Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1877040A1 (en) *	2005-04-25	2008-01-16	Teva Pharmaceuticals USA, Inc.	Extended release formulations
JP2009507047A (ja) *	2005-09-09	2009-02-19	ラボファームインコーポレイテッド	持続性薬物放出組成物
PT1931346E (pt) *	2005-09-09	2012-08-14	Angelini Labopharm Llc	Composição de trazodona para administração uma vez por dia
US20070160960A1 (en) *	2005-10-21	2007-07-12	Laser Shot, Inc.	System and method for calculating a projectile impact coordinates
RU2361591C1 (ru) *	2007-10-03	2009-07-20	Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон")	Противосудорожное лекарственное средство
FR2940910A1 (fr) *	2009-01-09	2010-07-16	Vetoquinol Sa	Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) *	2016-07-19	2016-10-12	南京正宽医药科技有限公司	一种卡马西平片及其制备方法
CN108125922A (zh) *	2018-01-14	2018-06-08	上海安必生制药技术有限公司	一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) *	1982-06-24	1982-06-24	Astra Laekemedel Ab	Pharmaceutical mixture
DK151608C (da) *	1982-08-13	1988-06-20	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) *	1986-08-07	1988-12-15	Ciba Geigy Ag	Therapeutisches system mit systemischer wirkung.
IL86211A (en) *	1987-05-04	1992-03-29	Ciba Geigy Ag	Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) *	1989-03-23	1994-07-05	Fmc Corporation	Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

1994
- 1994-07-01 DE DE19944423078 patent/DE4423078B4/de not_active Expired - Fee Related
1995
- 1995-06-22 CZ CZ19963826A patent/CZ288028B6/cs not_active IP Right Cessation
- 1995-06-22 WO PCT/DE1995/000805 patent/WO1996001112A1/de not_active Ceased
- 1995-06-22 CN CN95193915A patent/CN1101191C/zh not_active Expired - Fee Related
- 1995-06-22 ES ES95922407T patent/ES2122630T3/es not_active Expired - Lifetime
- 1995-06-22 KR KR1019960707549A patent/KR100344477B1/ko not_active Expired - Lifetime
- 1995-06-22 DE DE59503283T patent/DE59503283D1/de not_active Expired - Lifetime
- 1995-06-22 DK DK95922407T patent/DK0768882T3/da active
- 1995-06-22 HU HU9603565A patent/HU221486B/hu unknown
- 1995-06-22 US US08/776,266 patent/US5888545A/en not_active Expired - Lifetime
- 1995-06-22 GE GEAP19953512A patent/GEP19991819B/en unknown
- 1995-06-22 RU RU97101469A patent/RU2141825C1/ru active
- 1995-06-22 UA UA97010403A patent/UA32598C2/uk unknown
- 1995-06-22 JP JP8503611A patent/JPH10502358A/ja not_active Ceased
- 1995-06-22 SK SK1646-96A patent/SK282303B6/sk not_active IP Right Cessation
- 1995-06-22 BR BR9508202A patent/BR9508202A/pt not_active Application Discontinuation
- 1995-06-22 AT AT95922407T patent/ATE169818T1/de active
- 1995-06-22 EP EP95922407A patent/EP0768882B1/de not_active Expired - Lifetime
- 1995-06-22 EE EE9600202A patent/EE03954B1/et unknown
- 1995-06-22 CA CA002194216A patent/CA2194216A1/en not_active Abandoned
- 1995-06-22 PL PL95317996A patent/PL180979B1/pl unknown
1996
- 1996-12-28 BG BG101080A patent/BG62794B1/bg unknown
1997
- 1997-01-30 LV LVP-97-13A patent/LV11820B/lv unknown
- 1997-01-30 LT LT97-012A patent/LT4251B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1153475A (zh)	1997-07-02
KR100344477B1 (ko)	2002-11-23
EE03954B1 (et)	2003-02-17
EP0768882B1 (de)	1998-08-19
PL180979B1 (pl)	2001-05-31
ES2122630T3 (es)	1998-12-16
HU221486B (en)	2002-10-28
DE4423078B4 (de)	2005-01-13
BG101080A (en)	1997-08-29
DE4423078A1 (de)	1996-01-04
BR9508202A (pt)	1997-11-11
SK282303B6 (sk)	2002-01-07
CN1101191C (zh)	2003-02-12
HUT76821A (en)	1997-11-28
GEP19991819B (en)	1999-11-05
US5888545A (en)	1999-03-30
DK0768882T3 (da)	1999-05-25
HU9603565D0 (en)	1997-02-28
CZ288028B6 (cs)	2001-04-11
CA2194216A1 (en)	1996-01-18
SK164696A3 (en)	1997-06-04
LV11820A (lv)	1997-08-20
LT97012A (en)	1997-08-25
UA32598C2 (uk)	2001-02-15
RU2141825C1 (ru)	1999-11-27
DE59503283D1 (de)	1998-09-24
EP0768882A1 (de)	1997-04-23
BG62794B1 (bg)	2000-08-31
CZ382696A3 (en)	1997-05-14
LT4251B (en)	1997-12-29
LV11820B (en)	1997-12-20
WO1996001112A1 (de)	1996-01-18
ATE169818T1 (de)	1998-09-15
PL317996A1 (en)	1997-05-12
KR970703774A (ko)	1997-08-09
JPH10502358A (ja)	1998-03-03

Legal Events

Date	Code	Title	Description
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	KB4A	Valid patent at the end of a year	Effective date: 20091231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
HUP9904174A2 (hu)	2000-04-28	Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
DE69100991D1 (de)	1994-02-24	Pharmazeutische formulierungen.
DE69519685D1 (de)	2001-01-25	Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
UA29563C2 (uk)	2000-11-15	Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
HUP0203451A2 (hu)	2003-02-28	Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
CA2253980A1 (en)	1997-11-27	Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
BG100933A (en)	1997-07-31	Polymer coated tablets comprising amoxycilin and clavulanate
EP0382077A3 (de)	1991-07-31	Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
FR2752732B1 (fr)	1998-11-20	Forme galenique a liberation prolongee de milnacipran
DE69007623D1 (de)	1994-04-28	Arzneimittel mit verzögerter wirkstofffreigabe.
UA42061C2 (uk)	2001-10-15	Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
ES2051881T3 (es)	1994-07-01	Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
GR1002564B (el)	1997-02-03	Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
BR0009770A (pt)	2002-01-08	Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
ES2158101T3 (es)	2001-09-01	Formulaciones farmaceuticas efervescentes que contienen microcapsulas biodegradables de liberacion controlada.
NO992944L (no)	1999-06-16	Virkestoffbµrer for avgivelse av apomorfin i munnhulen
HRP20010684B1 (hr)	2011-01-31	Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
EE9600202A (et)	1997-06-16	Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
PT615754E (pt)	2002-11-29	Formas solidas de administracao oral de libertacao controlada flupertina
NO894616L (no)	1990-05-22	Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ATE290854T1 (de)	2005-04-15	Carbamazepinformulierung mit verzögerter freigabe
SE9501671D0 (sv)	1995-05-05	Method and composition for prevention of posterior capsule opacification
BR0012775A (pt)	2002-04-02	Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
GR3024854T3 (en)	1998-01-30	Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
DE59510583D1 (de)	2003-04-17	Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid